Breaking News | GenomeWeb

Breaking News

MIAMI, Sept 12 – Lion Bioscience (Nasdaq: LEON, Neuer Markt: LIO) of Heidelberg , Germany said Tuesday it would incorporate Electric Genetics’ expressed sequence tags clustering tool into its SRS data integration platform, representing a vote of confidence for the So

PARIS, Sept 12 - In July, Geneva Proteomics of Switzerland made a bold announcement, saying it planned to become the international leader in industrialized proteomics. Armed with some of the leading brains in proteomics and $40 million in venture capita

NEW YORK,   Sept 12 - Bruker Daltonics (Nasdaq: BDAL) of Billerica, Mass., said Tuesday it would sell 51 mass spectrometry machines to Geneva Proteomics as well as take an equity stake in the Swiss company. Fin

This story has been updated from an early version with comments from IBM, Incyte NEW YORK, Sept 11 - Incyte Genomics (Nasdaq: INCY) of Palo Alto, Calif., said Monday it would incorporate IBM’s (NYSE: IBM) data management software i

NEW YORK, Sept. 11 -- Affymetrix (Nasdaq: AFFX) of Santa Clara, Calif., said Monday it had licensed technology for low and medium density DNA arrays to reagent-provider Takara Shuzo of Kyoto, Japan.

NEW YORK, Sept 11 - Genomics company Illumina (Nasdaq: ILMN) reported Monday pro forma net losses of $5.3 million, or 25 cents a share, for the company’s fiscal second quarter, compared with l

Here is some text for the article Here is bullet. More inforation for the comming wave of anacromonius junk The functionality is all there. We have a glitch with the homepage ordering and I am finishing the navigation now.

NEW YORK, Sept 8 – Salomon Smith Barney initiated coverage of Genaissance Pharmaceuticals (Nasdaq: GNSC) with a Venture, Buy rating and issued a 12-month price target of $32 a share. Genaissance of New Haven, Conn., was trading up 1 1/16, or 4.8 percent

NEW YORK, Sept 8 – Salomon Smith Barney initiated coverage of Genaissance Pharmaceuticals (Nasdaq: GNSC) with a Venture, Buy rating and issued a 12-month price target of $32 a share.  

NEW YORK, Sept. 8 -- Seeking to extend the use of its model organism and comparative genomics technologies, Exelixis (Nasdaq: EXEL) said Thursday it had agreed to acquire agricultural genomics company Agritope (Nasdaq: AGTO) in an all stock deal valued at $68 million. Exelixis o

NEW YORK, Sept 7 - LION bioscience (Nasdaq: LEON) said on Thursday it had released genomeSCOUT 1.0, a software package for genome comparison and analysis. genomeSCOUT uses comparative genomics to help researchers gain information about the   functiona

NEW YORK, Sept 7 - The road to a better DNA chip is paved with gold, Northwestern University researchers report in the September 8 issue of Science .

NEW YORK, Sept 7 - DNA Sciences of Mountain View, Calif., announced on Thursday the opening of its genetic analysis facility, which seeks to find new links between genetics and disease. The facility, which was opened in collaboration with Amersham Pharmacia Biotech, will use more than 40 of AP

NEW YORK, Sept 7 – An international group of 30 public scientists are currently annotating the human genome with the hope of publishing the data in December, Eric Lander, director of MIT’s Whitehead Institute for Genome Research, said Thursday.

Genomics stocks closed sharply lower on Wednesday as the biotech sector tumbled for a second day due to profit-taking following the long holiday weekend, analysts said. Celera Genomics (NYSE: CRA) closed at 100 7/16, down 4 1/16, or 3.9 percent, following

NEW YORK, Sept 6 - Applied Biosystems (NYSE: PEB) said on Wednesday it had agreed to make a $3 million equity investment in software developer Genomica. The companies also signed an agreement under which Genomica will license its genetic-analysis object model to Applied Biosystem

Genomics stocks continued to fall on Wednesday as the biotech sector tumbled for a second day as investors took profits after the long holiday weekend.

Genomics stocks continue to lead the biotech sectors on a downward slide Wednesday morning. Celera Genomics dropped another 4.7 percent by mid-day after shedding 7 percent Tuesday.Incyte Genomics slipped another 4 percent following a 4.2 percent decline the day before.

NEW YORK, Sept.

NEW YORK, Sept 6  Amersham Pharmacia Biotech said on Wednesday it had invested $10 million in InforMax and also announced a strategic collaboration with the bioinformatics company. The deal represents the largest collaboration for InforMax of Rockville, Md., to date.

NEW YORK, Sept 6 - Pharmacopeia (Nasdaq: PCOP) said Wednesday it had completed the acquisition of the software subsidiaries of Oxford Molecular Group of Oxford, UK. The deal, which was valued at about $27 million, including cash and the assumption of certain liabilities, includes Oxford’s GCG

NEW YORK, Sept 6 - German pharmaceuticals group Schering AG intends to float its functional genomics biotech business next year, Reuters reported on Wednesday.

Pages

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.